loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 05b6bd57 36aa 47c3 Bcf6 2470ba42feb5 Applno 21344 Form Solution Intramuscular Dosage 250mg 5ml 50mg Ml - Drug Product Composition: Fulvestrant

    Menu

    Fulvestrant

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 40,781Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 21344 / DOSAGE - SOLUTION;INTRAMUSCULAR - 250MG/5ML (50MG/ML)

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FULVESTRANT(UNII: 22X328QOC4)
    (FULVESTRANT - UNII:22X328QOC4)     		FULVESTRANT50mg in 1

    Inactive Ingredients

    Ingredient Name
    Accord Healthcare Inc.
    AstraZeneca Pharmaceuticals LP
    BluePoint Laboratories
    EBEWE Pharma Ges.m.b.H. Nfg.KG
    GLENMARK PHARMACEUTICALS INC., USA
    HBT Labs, Inc.
    Hikma Pharmaceuticals USA Inc.
    Mylan Institutional LLC
    Northstar RxLLC
    Sagent Pharmaceuticals
    Zydus Pharmaceuticals USA Inc.
    ALCOHOL(3K9958V90M)
    BENZYL ALCOHOL(LKG8494WBH)
    BENZYL BENZOATE(N863NB338G)
    CASTOR OIL(D5340Y2I9G)